Sound Income Strategies LLC increased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Get Rating) by 10.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 48,269 shares of the company’s stock after purchasing an additional 4,538 shares during the period. Sound Income Strategies LLC’s holdings in Johnson & Johnson were worth $7,482,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in JNJ. Veracity Capital LLC grew its stake in Johnson & Johnson by 1.2% during the 4th quarter. Veracity Capital LLC now owns 5,027 shares of the company’s stock valued at $888,000 after acquiring an additional 59 shares in the last quarter. LCM Capital Management Inc grew its stake in shares of Johnson & Johnson by 0.7% in the 4th quarter. LCM Capital Management Inc now owns 9,437 shares of the company’s stock valued at $1,667,000 after buying an additional 61 shares during the period. Arbor Investment Advisors LLC grew its stake in shares of Johnson & Johnson by 2.3% in the 4th quarter. Arbor Investment Advisors LLC now owns 2,697 shares of the company’s stock valued at $476,000 after buying an additional 61 shares during the period. Sierra Capital LLC grew its stake in shares of Johnson & Johnson by 0.6% in the 4th quarter. Sierra Capital LLC now owns 10,036 shares of the company’s stock valued at $1,773,000 after buying an additional 61 shares during the period. Finally, Magnolia Capital Advisors LLC grew its stake in shares of Johnson & Johnson by 0.7% in the 3rd quarter. Magnolia Capital Advisors LLC now owns 8,883 shares of the company’s stock valued at $1,451,000 after buying an additional 62 shares during the period. Institutional investors and hedge funds own 67.57% of the company’s stock.
Johnson & Johnson Trading Down 0.2 %
Shares of NYSE:JNJ opened at $163.87 on Thursday. Johnson & Johnson has a 52 week low of $150.11 and a 52 week high of $183.35. The company’s 50 day moving average is $160.72 and its two-hundred day moving average is $163.68. The company has a current ratio of 1.07, a quick ratio of 0.85 and a debt-to-equity ratio of 0.49. The company has a market cap of $425.85 billion, a PE ratio of 34.28, a P/E/G ratio of 2.80 and a beta of 0.54.
Johnson & Johnson Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 6th. Shareholders of record on Tuesday, May 23rd were given a $1.19 dividend. The ex-dividend date of this dividend was Monday, May 22nd. This is an increase from Johnson & Johnson’s previous quarterly dividend of $1.13. This represents a $4.76 dividend on an annualized basis and a dividend yield of 2.90%. Johnson & Johnson’s dividend payout ratio is currently 99.58%.
Analyst Upgrades and Downgrades
JNJ has been the subject of several analyst reports. StockNews.com initiated coverage on shares of Johnson & Johnson in a research note on Thursday, May 18th. They issued a “strong-buy” rating for the company. Credit Suisse Group upped their price objective on shares of Johnson & Johnson from $168.00 to $170.00 in a report on Friday, May 5th. Raymond James decreased their price objective on shares of Johnson & Johnson from $185.00 to $181.00 and set an “outperform” rating on the stock in a report on Wednesday, April 19th. UBS Group began coverage on shares of Johnson & Johnson in a report on Tuesday, March 28th. They issued a “neutral” rating and a $164.00 price objective on the stock. Finally, Guggenheim began coverage on shares of Johnson & Johnson in a report on Tuesday, February 28th. They issued a “neutral” rating and a $161.00 price objective on the stock. Seven investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $171.57.
Insider Buying and Selling at Johnson & Johnson
In related news, EVP Kathryn E. Wengel sold 12,465 shares of the stock in a transaction on Monday, June 12th. The shares were sold at an average price of $160.00, for a total value of $1,994,400.00. Following the transaction, the executive vice president now directly owns 65,934 shares of the company’s stock, valued at approximately $10,549,440. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.20% of the company’s stock.
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets.
Featured Stories
- Get a free research report on Johnson & Johnson from StockNews.com
- Smartsheet Investors’ Hasty Exit Can Be Your Gain
- Agilent Technologies Stock: Ready to Rise off the Floor
- Oilfield Services Growing Faster Than Wider Energy Sector
- La-Z-Boy Reclines To The Buy Zone As Industry Normalizes
- Five stocks we like better than Johnson & Johnson
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
